These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

271 related items for PubMed ID: 31554638

  • 1. A Neuropilin-1 Antagonist Exerts Antitumor Immunity by Inhibiting the Suppressive Function of Intratumoral Regulatory T Cells.
    Jung K, Kim JA, Kim YJ, Lee HW, Kim CH, Haam S, Kim YS.
    Cancer Immunol Res; 2020 Jan; 8(1):46-56. PubMed ID: 31554638
    [Abstract] [Full Text] [Related]

  • 2. Immunoglobulin Fc-fused, neuropilin-1-specific peptide shows efficient tumor tissue penetration and inhibits tumor growth via anti-angiogenesis.
    Kim YJ, Bae J, Shin TH, Kang SH, Jeong M, Han Y, Park JH, Kim SK, Kim YS.
    J Control Release; 2015 Oct 28; 216():56-68. PubMed ID: 26260451
    [Abstract] [Full Text] [Related]

  • 3. Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity.
    Overacre-Delgoffe AE, Chikina M, Dadey RE, Yano H, Brunazzi EA, Shayan G, Horne W, Moskovitz JM, Kolls JK, Sander C, Shuai Y, Normolle DP, Kirkwood JM, Ferris RL, Delgoffe GM, Bruno TC, Workman CJ, Vignali DAA.
    Cell; 2017 Jun 01; 169(6):1130-1141.e11. PubMed ID: 28552348
    [Abstract] [Full Text] [Related]

  • 4. Prevalence of intratumoral regulatory T cells expressing neuropilin-1 is associated with poorer outcomes in patients with cancer.
    Chuckran CA, Cillo AR, Moskovitz J, Overacre-Delgoffe A, Somasundaram AS, Shan F, Magnon GC, Kunning SR, Abecassis I, Zureikat AH, Luketich J, Pennathur A, Sembrat J, Rojas M, Merrick DT, Taylor SE, Orr B, Modugno F, Buckanovich R, Schoen RE, Kim S, Duvvuri U, Zeh H, Edwards R, Kirkwood JM, Coffman L, Ferris RL, Bruno TC, Vignali DAA.
    Sci Transl Med; 2021 Dec 08; 13(623):eabf8495. PubMed ID: 34878821
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Immunoglobulin Fc-Fused Peptide without C-Terminal Arg or Lys Residue Augments Neuropilin-1-Dependent Tumor Vascular Permeability.
    Baek DS, Kim JH, Kim YJ, Kim YS.
    Mol Pharm; 2018 Feb 05; 15(2):394-402. PubMed ID: 29232521
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. NKG2D-Fc fusion protein promotes antitumor immunity through the depletion of immunosuppressive cells.
    Feng PH, Lam B, Tseng SH, Kung YJ, Farmer E, Cheng MA, Hung CF.
    Cancer Immunol Immunother; 2020 Oct 05; 69(10):2147-2155. PubMed ID: 32468232
    [Abstract] [Full Text] [Related]

  • 10. Construction and preclinical characterization of Fc-mGITRL for the immunotherapy of cancer.
    Hu P, Arias RS, Sadun RE, Nien YC, Zhang N, Sabzevari H, Lutsiak ME, Khawli LA, Epstein AL.
    Clin Cancer Res; 2008 Jan 15; 14(2):579-88. PubMed ID: 18223234
    [Abstract] [Full Text] [Related]

  • 11. Targeting CCR8 Induces Protective Antitumor Immunity and Enhances Vaccine-Induced Responses in Colon Cancer.
    Villarreal DO, L'Huillier A, Armington S, Mottershead C, Filippova EV, Coder BD, Petit RG, Princiotta MF.
    Cancer Res; 2018 Sep 15; 78(18):5340-5348. PubMed ID: 30026324
    [Abstract] [Full Text] [Related]

  • 12. Rapid Depletion of Intratumoral Regulatory T Cells Induces Synchronized CD8 T- and NK-cell Activation and IFNγ-Dependent Tumor Vessel Regression.
    Kurebayashi Y, Olkowski CP, Lane KC, Vasalatiy OV, Xu BC, Okada R, Furusawa A, Choyke PL, Kobayashi H, Sato N.
    Cancer Res; 2021 Jun 01; 81(11):3092-3104. PubMed ID: 33574087
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment.
    Budhu S, Schaer DA, Li Y, Toledo-Crow R, Panageas K, Yang X, Zhong H, Houghton AN, Silverstein SC, Merghoub T, Wolchok JD.
    Sci Signal; 2017 Aug 29; 10(494):. PubMed ID: 28851824
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Regulatory T Cell Insufficiency in Autoimmune Diabetes Is Driven by Selective Loss of Neuropilin-1 on Intraislet Regulatory T Cells.
    Grebinoski S, Pieklo G, Zhang Q, Visperas A, Cui J, Goulet J, Xiao H, Brunazzi EA, Cardello C, Herrada AA, Das J, Workman CJ, Vignali DAA.
    J Immunol; 2024 Sep 15; 213(6):779-794. PubMed ID: 39109924
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Dual Roles for Regulatory T-cell Depletion and Costimulatory Signaling in Agonistic GITR Targeting for Tumor Immunotherapy.
    Mahne AE, Mauze S, Joyce-Shaikh B, Xia J, Bowman EP, Beebe AM, Cua DJ, Jain R.
    Cancer Res; 2017 Mar 01; 77(5):1108-1118. PubMed ID: 28122327
    [Abstract] [Full Text] [Related]

  • 19. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody.
    Ha D, Tanaka A, Kibayashi T, Tanemura A, Sugiyama D, Wing JB, Lim EL, Teng KWW, Adeegbe D, Newell EW, Katayama I, Nishikawa H, Sakaguchi S.
    Proc Natl Acad Sci U S A; 2019 Jan 08; 116(2):609-618. PubMed ID: 30587582
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.